Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and ...
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to ...
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results